Here is how Bowman Consulting (BWMN) and Sims Metal Management Ltd. (SMSMY) have performed compared to their sector so far this year.

Jim Cramer breaks down why he's keeping an eye on shares of Lam Research.

S&P Global Inc. (SPGI) is rated a buy, supported by strong Q3 earnings, robust recurring revenue, and strategic acquisitions in private market data. SPGI's AI investments and early adoption, including the Kensho acquisition, drive product innovation, operational efficiency, and margin expansion across segments. The upcoming Mobility segment spin-off and recent With Intelligence acquisition enhance SPGI's focus on high-growth, high-margin business lines and private markets.

Rigetti's Q3 loss is narrower than estimates, but revenues decline as government contract delays hit sales and lower the gross margin.

From a technical perspective, Adma Biologics (ADMA) is looking like an interesting pick, as it just reached a key level of support. ADMA recently overtook the 20-day moving average, and this suggests a short-term bullish trend.

Sanara MedTech Inc. (SMTI) came out with quarterly earnings of $0.09 per share, beating the Zacks Consensus Estimate of a loss of $0.24 per share. This compares to a loss of $0.34 per share a year ago.

ATHENS, Greece, Nov. 12, 2025 (GLOBE NEWSWIRE) -- EuroHoldings Ltd. (NASDAQ: EHLD) (“EuroHoldings” or the “Company”) an owner and operator of ocean-going vessels and provider of seaborne transportation, announced today that it will release its financial results for the third quarter ended September 30, 2025 on November 17, 2025, before market opens in New York.

The company still needs a few big deals to move toward its ambition of a double-digit share of the AI data-center market.

New Policy Update Brings Innovative, Non-Drug Depression Treatment to Adolescents Across 26 States New Policy Update Brings Innovative, Non-Drug Depression Treatment to Adolescents Across 26 States

Rocket Lab USA NASDAQ: RKLB delivered a strong third quarter, and the market wasted no time responding. Shares climbed in after-hours trading after the company posted record revenue, showing that demand in both Electron launch services and Space Systems remains firmly in place.

BiomX Inc. ( PHGE ) Q3 2025 Earnings Call November 12, 2025 8:30 AM EST Company Participants Marina Wolfson - CFO & Secretary Jonathan Solomon - CEO & Director Conference Call Participants Joseph Pantginis - H.C. Wainwright & Co, LLC, Research Division Yale Jen - Laidlaw & Company (UK) Ltd.

HIVE's surging Bitcoin-mining capacity and AI-fueled HPC growth are likely to power strong fiscal second-quarter results despite crypto headwinds.

VCTR's October AUM climbed to $313B, driven by equity market gains and strength across key asset classes.

HUYA Inc. ( HUYA ) Q3 2025 Earnings Call November 12, 2025 5:00 AM EST Company Participants Junhong Huang - Acting Co-CEO, Senior VP & Director Lei Peng - CFO & Acting Co-CEO Conference Call Participants Rebecca Xu - Morgan Stanley, Research Division Yifan Ye - CLSA Limited, Research Division Ritchie Sun - HSBC Global Investment Research Fuk Lung Cheung - Citigroup Inc., Research Division Presentation Unknown Executive [Audio Gap] Huya's press release contains a reconciliation of the unaudited non-GAAP measures to the unaudited most directly comparable GAAP measures. With that, I'm pleased to turn the call over to our …

PagSeguro Digital Ltd. (PAGS) reached a significant support level, and could be a good pick for investors from a technical perspective.

Boston Scientific (BSX) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, BSX crossed above the 200-day moving average, suggesting a long-term bullish trend.

Adma Biologics (ADMA) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, ADMA broke through the 50-day moving average, which suggests a short-term bullish trend.

Although the revenue and EPS for HudBay Minerals (HBM) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Although the revenue and EPS for European Wax Center (EWCZ) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?